Podcast Interview: Chris Garabedian, CEO, AVI BioPharma - Pharmaceutical Executive

ADVERTISEMENT

Podcast Interview: Chris Garabedian, CEO, AVI BioPharma

Pharmaceutical Executive

Interview: Chris Garabedian

Chris Garabedian, CEO at AVI BioPharma, discusses his company's $291 million contract with the Defense Department, and how RNA-based therapeutics are being used to combat infectious diseases.

ADVERTISEMENT

blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here